Abstract
Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy in essential tremor (ET) targets the ventral intermediate nucleus hub region within the cerebello-thalamo-cortical tract (CTCT). Understanding the microstructural changes in the CTCT over time and their link to tremor improvement is crucial from a tremor-network perspective. We retrospectively analyzed tremor scores, lesion characteristics, and diffusion MRI-derived CTCT microstructural measures in 27 ET patient’s pre-treatment (T0), at 1 month (T2), and 6 months (T3) post-MRgFUS. Using probabilistic tractography, we created an average CTCT mask for assessing fractional anisotropy (FA), axial (AD), mean (MD), and radial diffusivity (RD) measures across time points. Significant tremor reduction was observed at T2 and T3. The Linear mixed effect analyses showed significant time effects for FA, MD, and AD. Relative to baseline, post-hoc comparisons showed a significant decrease of FA and AD at lesion site only for T2. Instead, there was a significant increase in AD and MD at T3 compared to T2 at lesion site, and remotely near the motor cortex. Lesion size and FA changes in the CTCT at T2 showed only trend-level correlations with tremor outcome. Stronger associations were observed for the thalamic lesion-tract overlap at T2, which were even more robust at T3. Dynamic microstructural changes suggest early axonal disruption at the lesion site and subsequent reorganization, with remote CTCT changes potentially indicating chronic degeneration. Meanwhile, microstructural measures show limited predictive value for longer-term tremor outcome compared with macroanatomical lesion-CTCT overlap. Yet, advanced diffusion imaging protocol could increase the sensitivity to predict MRgFUS clinical outcome.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
DRKS00016695
Funding Statement
The MRgFUS system was in part funded by the German Research Foundation (INST 1172/6441) and the University of Bonns Faculty of Medicine.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board (Ethikkommission an der Medizinischen Fakultät Bonn) gave their approval (Ethics no. 314/18)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All Data produced in the study contained patient related information which is not available publicly.
Abbreviations
- MRgFUS
- Magnetic Resonance Guided Focused Ultrasound
- ET
- Essential tremor
- VIM
- Vental intermediate Neucleus
- CTCT
- cerebello-thalamo-cortical tract
- T0
- Before MRgFUS
- T2
- 1 month after MRgFUS
- T3
- 6 months after MRgFUS
- CRST
- Clinical rating scores for tremor
- DWI
- Diffusion Weighted Imaging
- FA
- Fractional Anisotropy
- AD
- Axial Diffusivity
- MD
- Mean Diffusivity
